搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 24 小时
时间不限
过去 1 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
18 小时
Pancreatic cancer patient survival doubled with high dose of common vitamin, study finds
Researchers at the University of Iowa found that adding high-dose IV vitamin C to chemotherapy helped increase survival in ...
Cure Today
20 小时
Phase 3 Study for Advanced Pancreatic Cancer Meets Survival Goal
Patients with locally advanced pancreatic cancer demonstrated a two-month difference in survival with tumor-treating fields ...
8 小时
NovoCure: PANOVA-3 Data Suggests A Potential Game-Changer For Pancreatic Cancer
NovoCure's TTFields therapy, combined with standard chemotherapy, improves overall survival in advanced pancreatic cancer.
41 分钟
Novocure Has Already Doubled in 2024. Can It Soar Higher in 2025?
The life science industry recently gave folks diagnosed with pancreatic cancer the best news this group has received in a ...
oncnursingnews
13 小时
Addition of Concomitant TTFields Induces OS Benefit in Unresectable Pancreatic Cancer
The phase 3 PANOVA-3 trial, designed to evaluate concomitant treatment with tumor treating fields and chemotherapy, met its ...
Stockhead on MSN
14 小时
Dr Boreham’s Crucible: Will ditching its baggage help this pancreatic cancer-targeting ...
Oncosil Medical's investors have been promised a “catalyst rich” 2025 and 2026, including expected filings to the local TGA ...
News Medical on MSN
18 小时
Annual report reveals more cancers are being treated with personalized therapies before surgery
Breast, bladder, and pancreatic cancers are increasingly being treated with a broad range of therapies before a patient ...
health.economictimes.indiatimes
9 小时
US FDA approves Merus' therapy to treat lung, pancreatic cancers
The therapy, branded as Bizengri, targets the NRG1 gene, which is associated with formation and progression of several tumors. The company did not immediately respond to a Reuters request for comment ...
6 小时
on MSN
US drug body approves Merus' therapy for lung, pancreatic cancer patients
The therapy, branded as Bizengri, targets the NRG1 gene, which is associated with formation and progression of several tumors ...
Targeted Oncology
18 小时
DSMB Approves Continued GOBLET Cohort 5 Enrollment in Pancreatic Cancer
Enrollment in cohort 5 of the phase 1/2 GOBLET study will resume after the Data Safety Monitoring Board’s safety review.
Stocktwits on MSN
2 小时
News Movers: Yesterday’s Hottest News That Could Move the Needle Today
WealthyVC.com scans North America’s 10,000+ publicly listed stocks across all seven exchanges to find the market-moving news ...
Cure Today
12 小时
FDA Approves Bizengri for Some with NSCLC, Pancreatic Adenocarcinoma
The FDA has approved the first systemic therapy for patients with NSCLC or pancreatic adenocarcinoma with an NRG1 gene fusion.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈